M. Pierre

Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1

J. Puymirat, F. Rigo, C. Bennett, 2022, Gene therapy.

Deciphering the mechanisms underlying brain alterations and cognitive impairment in congenital myotonic dystrophy

J. Puymirat, M. Chahine, Marion Pierre, 2021, Neurobiology of Disease.

Neurobiology of Disease

M. Lévesque, D. Butterfield, F. Cicchetti, 2015 .

Combining NGN2 programming and dopaminergic patterning for a rapid and efficient generation of hiPSC-derived midbrain neurons

Thomas M. Durcan, F. Calon, V. Émond, 2022, Scientific Reports.

Deciphering DSC2 arrhythmogenic cardiomyopathy electrical instability: From ion channels to ECG and tailored drug therapy

X. Nissan, H. Delanoe-Ayari, A. Meli, 2021, Clinical and translational medicine.

NaV1.5 knockout in iPSCs: a novel approach to study NaV1.5 variants in a human cardiomyocyte environment

M. Chahine, Mohammed Djemai, Hugo Poulin, 2021, Scientific Reports.